Log In
BCIQ
Print this Print this
 

ACT-334441

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionSphingosine 1 phosphate receptor modulator
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today